Diabetes & Metabolism

Papers
(The H4-Index of Diabetes & Metabolism is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Efficacy and safety of once-weekly semaglutide 1.0 mg vs once-daily liraglutide 1.2 mg as add-on to 1–3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10)209
Metformin and COVID-19: From cellular mechanisms to reduced mortality132
Patients with diabetes are at higher risk for severe illness from COVID-19115
Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports107
Body mass index and outcome in patients with COVID-19: A dose–response meta-analysis98
Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients85
NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment83
Efficacy and safety of anti-hyperglycaemic drugs in patients with non-alcoholic fatty liver disease with or without diabetes: An updated systematic review of randomized controlled trials78
Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes68
Socioeconomic inequalities and type 2 diabetes complications: A systematic review67
Trimethylamine N-oxide levels are associated with NASH in obese subjects with type 2 diabetes57
Routine use of statins and increased COVID-19 related mortality in inpatients with type 2 diabetes: Results from the CORONADO study55
Cardiovascular disease in type 1 diabetes: A review of epidemiological data and underlying mechanisms54
Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-1954
A systematic review of nudge theories and strategies used to influence adult health behaviour and outcome in diabetes management54
Effects of COVID-19 pandemic lockdown on gestational diabetes mellitus: A retrospective study51
Screening for non-alcoholic fatty liver disease using liver stiffness measurement and its association with chronic kidney disease and cardiovascular complications in patients with type 2 diabetes46
Effects of 12-week treatment with dapagliflozin and gliclazide on faecal microbiome: Results of a double-blind randomized trial in patients with type 2 diabetes41
Elevated triglyceride–glucose index predicts risk of incident ischaemic stroke: The Rural Chinese cohort study40
Meat and fish intake and type 2 diabetes: Dose–response meta-analysis of prospective cohort studies39
Glucose variability and diabetes complications: Risk factor or biomarker? Can we disentangle the “Gordian Knot”?33
Is the type 2 diabetes epidemic plateauing in France? A nationwide population-based study32
Statins and clinical outcomes with COVID-19: Meta-analyses of observational studies32
Adiponectin to leptin ratio reflects inflammatory burden and survival in COVID-1932
Smoking and diabetes interplay: A comprehensive review and joint statement32
DPP-4 inhibition and COVID-19: From initial concerns to recent expectations31
Fulminant type 1 diabetes after COVID-19 vaccination29
Detrimental effects of metabolic dysfunction-associated fatty liver disease and increased neutrophil-to-lymphocyte ratio on severity of COVID-1927
Regulation of hepatokine gene expression in response to fasting and feeding: Influence of PPAR-α and insulin-dependent signalling in hepatocytes27
0.034752130508423